Your browser doesn't support javascript.
loading
Cell type-specific manifestations of cortical thickness heterogeneity in schizophrenia.
Di Biase, Maria A; Geaghan, Michael P; Reay, William R; Seidlitz, Jakob; Weickert, Cynthia Shannon; Pébay, Alice; Green, Melissa J; Quidé, Yann; Atkins, Joshua R; Coleman, Michael J; Bouix, Sylvain; Knyazhanskaya, Evdokiya E; Lyall, Amanda E; Pasternak, Ofer; Kubicki, Marek; Rathi, Yogesh; Visco, Andrew; Gaunnac, Megan; Lv, Jinglei; Mesholam-Gately, Raquelle I; Lewandowski, Kathryn E; Holt, Daphne J; Keshavan, Matcheri S; Pantelis, Christos; Öngür, Dost; Breier, Alan; Cairns, Murray J; Shenton, Martha E; Zalesky, Andrew.
Afiliação
  • Di Biase MA; Melbourne Neuropsychiatry Centre, Department of Psychiatry, The University of Melbourne and Melbourne Health, Carlton South, VIC, Australia. dibiasem@unimelb.edu.au.
  • Geaghan MP; Department of Psychiatry, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. dibiasem@unimelb.edu.au.
  • Reay WR; School of Biomedical Sciences and Pharmacy, University of Newcastle, Newcastle, NSW, Australia.
  • Seidlitz J; Centre for Brain and Mental Health Research, Hunter Medical Research Institute, Newcastle, NSW, Australia.
  • Weickert CS; School of Biomedical Sciences and Pharmacy, University of Newcastle, Newcastle, NSW, Australia.
  • Pébay A; Centre for Brain and Mental Health Research, Hunter Medical Research Institute, Newcastle, NSW, Australia.
  • Green MJ; Department of Child and Adolescent Psychiatry and Behavioral Science, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
  • Quidé Y; Department of Psychiatry, University of Pennsylvania, Philadelphia, PA, USA.
  • Atkins JR; Neuroscience Research Australia, Randwick, NSW, Australia.
  • Coleman MJ; Discipline of Psychiatry and Mental Health, University of New South Wales, Sydney, NSW, Australia.
  • Bouix S; Department of Neuroscience & Physiology, Upstate Medical University, Syracuse, NY, USA.
  • Knyazhanskaya EE; Department of Anatomy and Physiology, School of Biomedical Sciences, The University of Melbourne, Melbourne, VIC, Australia.
  • Lyall AE; Department of Surgery, Royal Melbourne Hospital, Melbourne Medical School, The University of Melbourne, Melbourne, VIC, Australia.
  • Pasternak O; Neuroscience Research Australia, Randwick, NSW, Australia.
  • Kubicki M; Discipline of Psychiatry and Mental Health, University of New South Wales, Sydney, NSW, Australia.
  • Rathi Y; Neuroscience Research Australia, Randwick, NSW, Australia.
  • Visco A; Discipline of Psychiatry and Mental Health, University of New South Wales, Sydney, NSW, Australia.
  • Gaunnac M; School of Biomedical Sciences and Pharmacy, University of Newcastle, Newcastle, NSW, Australia.
  • Lv J; Department of Psychiatry, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • Mesholam-Gately RI; Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • Lewandowski KE; Department of Psychiatry, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • Holt DJ; Department of Psychiatry, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • Keshavan MS; Department of Psychiatry, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • Pantelis C; Department of Psychiatry, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • Öngür D; Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • Breier A; Department of Psychiatry, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • Cairns MJ; Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • Shenton ME; Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
  • Zalesky A; Department of Psychiatry, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Mol Psychiatry ; 27(4): 2052-2060, 2022 04.
Article em En | MEDLINE | ID: mdl-35145230
ABSTRACT
Brain morphology differs markedly between individuals with schizophrenia, but the cellular and genetic basis of this heterogeneity is poorly understood. Here, we sought to determine whether cortical thickness (CTh) heterogeneity in schizophrenia relates to interregional variation in distinct neural cell types, as inferred from established gene expression data and person-specific genomic variation. This study comprised 1849 participants in total, including a discovery (140 cases and 1267 controls) and a validation cohort (335 cases and 185 controls). To characterize CTh heterogeneity, normative ranges were established for 34 cortical regions and the extent of deviation from these ranges was measured for each individual with schizophrenia. CTh deviations were explained by interregional gene expression levels of five out of seven neural cell types examined (1) astrocytes; (2) endothelial cells; (3) oligodendrocyte progenitor cells (OPCs); (4) excitatory neurons; and (5) inhibitory neurons. Regional alignment between CTh alterations with cell type transcriptional maps distinguished broad patient subtypes, which were validated against genomic data drawn from the same individuals. In a predominantly neuronal/endothelial subtype (22% of patients), CTh deviations covaried with polygenic risk for schizophrenia (sczPRS) calculated specifically from genes marking neuronal and endothelial cells (r = -0.40, p = 0.010). Whereas, in a predominantly glia/OPC subtype (43% of patients), CTh deviations covaried with sczPRS calculated from glia and OPC-linked genes (r = -0.30, p = 0.028). This multi-scale analysis of genomic, transcriptomic, and brain phenotypic data may indicate that CTh heterogeneity in schizophrenia relates to inter-individual variation in cell-type specific functions. Decomposing heterogeneity in relation to cortical cell types enables prioritization of schizophrenia subsets for future disease modeling efforts.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Esquizofrenia Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Mol Psychiatry Assunto da revista: BIOLOGIA MOLECULAR / PSIQUIATRIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Austrália

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Esquizofrenia Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Mol Psychiatry Assunto da revista: BIOLOGIA MOLECULAR / PSIQUIATRIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Austrália